Market Research Reports and Industry Reports

Global Pharmaceutical & Biotechnology Outlook 2013: India Pharma

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • PURCHASE BY
    SECTION
India pharma rode on the wave of bunched up patent expiries in the US with many Para IV launches in 2012. In addition, it also benefited from the continuing high teen growth of Indian pharma market. With patent expiries in the US dwindling from $30b in 2012 to $10b in 2013 (small molecules), Indian generic companies will now need to focus on complex generics that offer sustainability of earnings. Locally acting drugs and targeted drug delivery products make up for the bulk of complex formulation generics. We have analyzed this space and have provided a fairly comprehensive list of products falling under these categories indicating that topical drugs remains the most near term opportunity for generics. Inhalers offer the most lucrative opportunity, though not before 2016.

Our growth outlook on Indian market continues to remain optimistic with 15-18% growth. This is based on the silent reforms in India that started with implementation of a strict GMP (Good Manufacturing Practices) in 2005, continued with implementation of GLP (Good Laboratories Practices) in 2011 and now the bar coding norms at primary and secondary levels. All these continue to put pressure on the very small manufacturer ultimately leading to industry consolidation something that augurs well for worlds most fragmented pharma market. We do not see any negative impact due to the newly announced National Pharma Pricing Policy (NPPP) due to its emphasis on market price based pricing policy.

Our top pick remains Sun Pharma as it remains the best positioned to tide over the patent cliff with its latest acquisitions, DUSA and URL Pharma. A strong balance sheet further allows it to acquire more such high value targets. We also recommend Natco Pharma for its focus on complex generics like Copaxone, Revlimid and Tamiflu. Besides this, its domestic market strategy targeted at gaining Compulsory License on high value oncology products too remains lucrative.
Key Topics Covered
Branded Liposomal Drugs and Generic Approvals in US
2. Branded Colon Targeted Drugs and Generic Approvals in US
3. Branded Transdermal Drugs and Generic Approvals in US
4. Branded Topical Drugs and Generic Approvals in US
5. Acquisitions in Dermatology Segment
6. Branded Inhalation Drugs and Generic Approvals in US
7. History of Wholesale Price Indices in India
8. Ciplas Inhaler Portfolio Approved Products and Competitive Landscape
9. Ciplas Inhaler Portfolio Pipeline Products and Competitive Landscape

List Of Tables

N/A

List Of Figures

Branded Liposomal Drugs and Generic Approvals in US
2. Branded Colon Targeted Drugs and Generic Approvals in US
3. Branded Transdermal Drugs and Generic Approvals in US
4. Branded Topical Drugs and Generic Approvals in US
5. Acquisitions in Dermatology Segment
6. Branded Inhalation Drugs and Generic Approvals in US
7. History of Wholesale Price Indices in India
8. Ciplas Inhaler Portfolio Approved Products and Competitive Landscape
9. Ciplas Inhaler Portfolio Pipeline Products and Competitive Landscape

Global γ- linolenic acid (GLA) Market Professional Survey Report 2017

Notes:Production, means the output of - linolenic acid (GLA)Revenue, means the sales value of - linolenic acid (GLA)This report studies - linolenic acid (GLA) in Global market, especially in North

USD 3500View Report

Global β-Amylase Market Professional Survey Report 2017

Notes:Production, means the output of -AmylaseRevenue, means the sales value of -AmylaseThis report studies -Amylase in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with

USD 3500View Report

Global Zirconium Oxide Flap Disc Market Professional Survey Report 2017

Notes:Production, means the output of Zirconium Oxide Flap DiscRevenue, means the sales value of Zirconium Oxide Flap DiscThis report studies Zirconium Oxide Flap Disc in Global market, especially in North

USD 3500View Report

Global Pharmaceutical Labeling Market Research Report 2017

Notes:Production, means the output of Pharmaceutical LabelingRevenue, means the sales value of Pharmaceutical LabelingThis report studies Pharmaceutical Labeling in Global market, especially in North America, Europe, China, Japan, Southeast Asia

USD 2900View Report

Global Pharmaceutical Testing Services Market Size, Status and Forecast 2022

Notes:Production, means the output of Pharmaceutical Testing ServicesRevenue, means the sales value of Pharmaceutical Testing ServicesThis report studies the global Pharmaceutical Testing Services market, analyzes and researches the Pharmaceutical Testing

USD 3300View Report

Global Pharmaceutical Grade Sodium Chloride Market Research Report 2017

Notes:Production, means the output of Pharmaceutical Grade Sodium ChlorideRevenue, means the sales value of Pharmaceutical Grade Sodium ChlorideThis report studies Pharmaceutical Grade Sodium Chloride in Global market, especially in North

USD 2900View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
If you want to purchase particular section from this report then kindly contact us at contact@aarkstore.com.

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    $ 2500
  • Site Licence    $ 5000
  • Enterprisewide Licence    $ 7500
$ 2500

Reports Details

Published Date : Jan 2013
No. of Pages :50
Country :Global
Category :Healthcare
Publisher :MP Advisors
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment